<DOC>
	<DOCNO>NCT02083276</DOCNO>
	<brief_summary>The mainstay treat symptomatic asymptomatic genital Chlamydia trachomatis infection macrolide antibiotic form azithromycin , alternatively tetracycline antibiotic form doxycycline . Studies late ninety find single dose 1 g azithromycin equally effective 7 day course 200 mg doxycycline day . However , recent study report increase treatment failure may indicate resistance macrolide antibiotic among Chlamydia trachomatis evolve . Research regard bacterial specie indicate high frequency mutation base resistance conjunction azithromycin use , i.e . treat Mycoplasma genitalium infection . There case report tetracycline resistance among human Chlamydia isolates , recent study suggest might decrease effectiveness also doxycycline . Veterinaries several year observe increase prevalence tetracycline resistance among Chlamydia suis . Within Chlamydia population promiscuous horizontal gene transfer . If current trend decline cure rate continue , investigator might face situation document effective treatment Chlamydia trachomatis infection . This underline urgent need expand number document treatment option mecillinam seem one option warrant investigation . The objective study prove concept treat genital Chlamydia trachomatis mecillinam ( Pivmecillinamhydrochlorid ) .</brief_summary>
	<brief_title>Mecillinam Treatment Genital Chlamydia Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Chlamydia Infections</mesh_term>
	<mesh_term>Urethritis</mesh_term>
	<mesh_term>Amdinocillin</mesh_term>
	<criteria>Proficient oral write Norwegian Positive NAAT first void urine Chlamydia trachomatis Negative NAAT first void urine Mycoplasma genitalium Heterosexual male Asymptomatic Known allergy mecillinam , penicillin cephalosporines Metabolic anomaly aciduric type Apparent underweight Use mecillinam within last two month Under treatment Valproat , antiinfective drug , immunomodulating medication In opinion investigator , obvious reason patient fails adhere treatment followup protocol</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Chlamydia trachomatis</keyword>
	<keyword>Urethritis</keyword>
	<keyword>Genital Diseases , Male</keyword>
</DOC>